Integrated or stand alone Drug Discovery services (from hit findings to IND), to discover and evaluate the therapies of tomorrow together.
A premium complete, integrated service offer for radiopharmaceuticals drug discovery and generation
Value creation through innovative technologies & R&D partnerships
ONCODESIGN strengthens the intellectual property of ODS 101 in treating inflammatory bowel disease
For Oncodesign, artificial intelligence (AI) is a powerful tool for accelerating and making drug development more reliable.
Optimization of data use to enhance and accelerate Drug Discovery processes in oncology
For more than 25 years, Oncodesign has been investing in precision medicine innovation technologies, which are essential from the very first stages of the Drug Discovery process.
Oncodesign’s mission is to discover new innovative therapies that are effective against cancers and serious diseases with no known treatments.
Learn how current in vivo preclinical models meet the needs of microbiome research and innovation while outlining their limitations and the challenges still to be overcome in this growing field.
Learn how to select the most appropriate COVID-19 animal model for preclinical studies in this webinar
Learn how the DRIVE-MRT solution enables the rationalization, design & optimization of targeted & effective radiopharmaceuticals against specific cancers.
18 rue Jean Mazen - FR - 21000 Dijon Tel.+33 380 788 260
Receive our general letter or our financial news!